paclitaxel has been researched along with Weight Gain in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hardy, RW; Rezonzew, G; Siegal, GP; Wang, D; Zhao, X | 1 |
| Albertsson, P; Lennernäs, B; Lennernäs, H; Norrby, K | 1 |
| Alberts, DS; Barakat, R; Hess, LM; Ozols, RF; Tian, C | 1 |
| Akrivos, T; Dertimas, V; Iavazzo, C; Kalinoglou, N; Katsoulis, M; Vorgias, G | 1 |
| Chikazawa, H; Hattori, N; Hiraiwa, E; Ishikawa, K; Kadota, T; Kawano, S; Koizumi, S; Kondoh, H; Kuroyanagi, K; Sakakura, K | 1 |
| Chikazawa, H; Hattori, N; Hiraiwa, E; Ishikawa, K; Kai, S; Kawano, S; Kohmura, H; Koizumi, S; Kondoh, H; Kuroyanagi, K | 2 |
| Aragao, BC; Cabral, LO; Guimaraes, RC; Murad, AM; Petroianu, A; Scalabrini-Neto, AO | 1 |
1 trial(s) available for paclitaxel and Weight Gain
| Article | Year |
|---|---|
Phase II trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer: a novel, safe, and effective regimen.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Analgesics; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prospective Studies; Quality of Life; Remission Induction; Reoperation; Safety; Stomach Neoplasms; Survival Rate; Weight Gain | 1999 |
7 other study(ies) available for paclitaxel and Weight Gain
| Article | Year |
|---|---|
Diet modulation is an effective complementary agent in preventing and treating breast cancer lung metastasis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Diet; Feeding Behavior; Female; Humans; Lung Neoplasms; Mice; Mice, Nude; Paclitaxel; Stearic Acids; Weight Gain | 2014 |
Chemotherapy and antiangiogenesis--drug-specific, dose-related effects.
Topics: Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Endothelial Growth Factors; Etoposide; Fluorouracil; Humans; Injections, Intravenous; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Mesentery; Methotrexate; Neovascularization, Physiologic; Paclitaxel; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Weight Gain | 2003 |
Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Body Weight; Carboplatin; Carcinoma; Cisplatin; Clinical Trials, Phase III as Topic; Cystadenocarcinoma, Serous; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Prognosis; Randomized Controlled Trials as Topic; Retrospective Studies; United States; Weight Gain; Weight Loss | 2007 |
Primary peritoneal serous papillary carcinoma: clinical and laboratory characteristics.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appetite; Ascites; CA-125 Antigen; Carboplatin; Cisplatin; Constipation; Cystadenocarcinoma, Serous; Female; Gynecologic Surgical Procedures; Humans; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Retrospective Studies; Weight Gain | 2008 |
[Toxicity studies of paclitaxel. (II)--One-month intermittent intravenous toxicity in rats].
Topics: Alopecia; Animals; Atrophy; Blood Cell Count; Bone Marrow; Drug Administration Schedule; Eating; Female; Hematopoiesis; Injections, Intravenous; Male; Paclitaxel; Rats; Rats, Sprague-Dawley; Spermatogenesis; Spleen; Testis; Thymus Gland; Weight Gain | 1994 |
[Reproductive and developmental toxicity studies of paclitaxel. (I)--Intravenous administration to rats prior to and in the early stages of pregnancy].
Topics: Adrenal Glands; Animals; Embryonic and Fetal Development; Female; Fertility; Gestational Age; Injections, Intravenous; Male; Organ Size; Ovary; Paclitaxel; Pregnancy; Rats; Rats, Sprague-Dawley; Reproduction; Weight Gain | 1994 |
[Reproductive and developmental toxicity studies of paclitaxel. (III)--Intravenous administration to rats during the perinatal and lactation periods].
Topics: Animals; Atrophy; Eating; Embryonic and Fetal Development; Female; Gestational Age; Heart; Injections, Intravenous; Lactation; Liver; Male; Organ Size; Paclitaxel; Postpartum Period; Pregnancy; Rats; Rats, Sprague-Dawley; Reproduction; Spleen; Thymus Gland; Uterus; Weight Gain | 1994 |